Mucosal vaccines are designed to target the mucous membranes of the body, such as those in the nose, mouth, lungs, and gastrointestinal tract, where many pathogens first enter the body. These vaccines stimulate the immune system at the site of infection, providing protection before the pathogen can spread to other parts of the body. Mucosal immunity is crucial for combating diseases like influenza, rotavirus, and COVID-19, where the primary route of infection is through the mucosal surfaces. Delivery strategies for mucosal vaccines have evolved to ensure they effectively target these sites. Nasal sprays, oral vaccines, and aerosolized formulations are some of the methods being explored to administer mucosal vaccines. These delivery systems need to overcome challenges such as ensuring stability and effectively targeting the right cells in the mucosal tissues. Advancing mucosal vaccine technology has the potential to provide more effective and user-friendly vaccines, especially for respiratory and gastrointestinal infections.
Submit your abstract Today
